Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Eiko Lifesciences Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Eiko Lifesciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Eiko Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended August 08, 2025

    14 Aug 2025, 6:20PM As of August 2025, 37.12% is owned by Indian Promoters and 62.89% by Public. <p align=justify> Top five Promoters holding highest number of shares of
  • Eiko Lifesciences - Compliance Under Regulation 36 Of The SEBI (Listing Obligations And Disclosures Requirements) Regulations

    1 Aug 2025, 6:45PM Letter to Shareholders u/r 36 of SEBI LODR
  • Eiko Lifesciences - Reg. 34 (1) Annual Report.

    30 Jul 2025, 7:20PM Reg 34(1)-Annual Report for Financial Year 2024-25
  • Eiko Lifesciences - Notice Of The 48Th AGM Of The Company For The Financial Year 2024-25

    29 Jul 2025, 7:47PM 48th AGM of the Company to be held on Friday, 05th September, 2025 at 4:00 PM (IST)
  • Eiko Lifesciences - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    29 Jul 2025, 7:33PM Increase in Authorized SHare Capital from 14cr to 20cr.
  • Eiko Lifesciences - Announcement under Regulation 30 (LODR)-Change in Management

    29 Jul 2025, 7:30PM Resignation of Mr. Umesh Ravindranath More (DIN: 09044162)
  • Eiko Lifesciences - Announcement under Regulation 30 (LODR)-Change in Management

    29 Jul 2025, 7:23PM Appointment & Re-appointment of Directors
  • Eiko Lifesciences Q1 net profit jumps 97.14% at Rs 0.69 cr

    29 Jul 2025, 7:22PM The company reported standalone net profit of Rs 0.69 crore for the quarter ended June 30, 2025 as compared to Rs 0.35 crore in the same period last y
  • Eiko Lifesciences - Board Meeting Outcome for Outcome Of The Board Meeting

    29 Jul 2025, 7:18PM As per attachment
  • Eiko Lifesciences - Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares

    29 Jul 2025, 3:51PM As per attachment
  • Eiko Lifesciences - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations

    24 Jul 2025, 3:26PM Eiko Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider an
  • Eiko Lifesciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:50PM As of June 2025, 36.74% is owned by Indian Promoters and 63.26% by Public. <p align=justify> Top five Promoters holding highest number of shares of Ei
  • Eiko Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    11 Jul 2025, 5:57PM Certificate under Regulation 74(5) of the SEBI (Depositories and participants) Regulation, 2018 for quarter ended 30th June 2025.
  • Eiko Lifesciences - Clarification On Price Movement

    4 Jul 2025, 5:58PM Please refer to your Email dated 04th July, 2025 regarding clarification on price movement. In this connection company wishes to inform that it has no
  • Eiko Lifesciences - Clarification sought from Eiko Lifesciences Ltd

    4 Jul 2025, 5:10PM The Exchange has sought clarification from Eiko Lifesciences Ltd on July 4, 2025, with reference to significant movement in price, in order to ensure

Key fundamentals

Evaluate the intrinsic value of Eiko Lifesciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 58.1777 50.6783 29.4223 33.1827 14.2847
Liabilities 58.1777 50.6783 29.4223 33.1827 14.2847
Equity 13.7627 12.8728 8.3163 8.3163 3.82
Gross Profit 1.7094 1.6127 0.9545 1.2953 0.5218
Net Profit 1.7408 0.7515 0.7688 0.7057 0.6143
Cash From Operating Activities 2.0461 -7.0797 4.2238 -7.7273 -4.256
NPM(%) 5.35 2.69 4.19 2.77 5.12
Revenue 32.4918 27.9293 18.3214 25.4119 11.9905
Expenses 30.7824 26.3166 17.3669 24.1166 11.4687
ROE(%) 3.06 1.32 1.35 1.24 1.08

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Eiko Lifesciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sugal and Damani Share Brokers Ltd 92.00 -1.60 10.75 32.82 75.99 0.00
360 One Wam Ltd 1017.10 -2.44 39.01 2064.17 2508.84 0.00
Arman Holdings Ltd 106.95 4.24 1188.33 27.36 -0.29 0.00
Asia Capital Ltd 17.37 4.95 24.46 16.24 9.71 0.00

Company Info

Narendra Investments (Delhi) Limited, incorporated on 7th January 1977, is an Investment Company listed on the Ahmedabad Stock Exchange and Delhi Stock Exchange Ltd.MAIN OBJECTS OF THE COMPANYTo carry on the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest in any shares, bonds, stocks, obligations issued or guaranteed by any company constituted and carrying on business in India or elsewhere and debentures, debenture-stocks, bonds, obligations and securities issued or guaranteed by any Government, State, Sovereign, Commissioners Central or Provincial, public body or authority supreme, municipal, local or otherwise in India or elsewhere either out of its own funds or out of funds that it might borrow. 2016 -Listing of equity shares of Narendra Investments (Delhi) Ltd 2021 -Company name has changed to Eiko Lifesciences Ltd. from Narendra Investments (Delhi) Ltd.. 2023 -The company issued rights shares of Rs. 10 in the ratio of 2:3 at a premium of Rs. 35 per share. 2024 -The Company entered into definitive business agreement with Vivacious Pharmatex Private Limited.

Narendra Investments (Delhi) Limited, incorporated on 7th January 1977, is an Investment Company listed on the Ahmedabad Stock Exchange and Delhi Stock Exchange Ltd.MAIN OBJECTS OF THE COMPANYTo carry on the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest in any shares, bonds, stocks, obligations issued or guaranteed by any company constituted and carrying on business in India or elsewhere and debentures, debenture-stocks, bonds, obligations and securities issued or guaranteed by any Government, State, Sovereign, Commissioners Central or Provincial, public body or authority supreme, municipal, local or otherwise in India or elsewhere either out of its own funds or out of funds that it might borrow. 2016 -Listing of equity shares of Narendra Investments (Delhi) Ltd 2021 -Company name has changed to Eiko Lifesciences Ltd. from Narendra Investments (Delhi) Ltd.. 2023 -The company issued rights shares of Rs. 10 in the ratio of 2:3 at a premium of Rs. 35 per share. 2024 -The Company entered into definitive business agreement with Vivacious Pharmatex Private Limited.

Read More

Parent Organisation

Eiko Lifesciences Ltd.

Founded

07/01/1977

Managing Director

NSE Symbol

FAQ

The current price of Eiko Lifesciences Ltd is

The 52-week high for Eiko Lifesciences Ltd is

The market capitalization of Eiko Lifesciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Eiko Lifesciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Eiko Lifesciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Eiko Lifesciences Ltd shares.

The CEO of Eiko Lifesciences Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT